Login

Switch On Your HIV Smarts.

Author Archives: Liz Highleyman

New European Guidelines Recommend ART for All, PrEP for Those at Risk

New European Guidelines Recommend ART for All, PrEP for Those at Risk

, by Liz Highleyman

European AIDS Clinical Society treatment guidelines align with U.S. recommendations on universal HIV treatment but extend PrEP to non-daily dosing. Read More

Is Dolutegravir Alone Enough to Control HIV?

Is Dolutegravir Alone Enough to Control HIV?

, by Liz Highleyman

Results of studies presented at the European AIDS Conference could lead to simpler, better tolerated, and easier to take regimens for people with difficult-to-treat HIV. Read More

PrEP demonstration project: Modest bone density loss observed among young men

PrEP demonstration project: Modest bone density loss observed among young men

, by Liz Highleyman

Bone density loss may occur in young people taking Truvada for PrEP, but long-term implications are not yet clear. Read More

Large Study Finds Higher Incidence of Some Cancers among People with HIV

Large Study Finds Higher Incidence of Some Cancers among People with HIV

, by Liz Highleyman

People with HIV experience higher rates of some non-AIDS defining cancers according to a recent large-scale study. Read More

ICAAC 2015: Stribild Superior for Women; Better Safety & Efficacy of TAF

ICAAC 2015: Stribild Superior for Women; Better Safety & Efficacy of TAF

, by Liz Highleyman

Find out what a recent study says about HIV treatment specific to women and how a new form of tenofovir is outperforming its predecessor. Read More